NextCure Q3 EPS $(1.29) Beats $(1.43) Estimate
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings Beats
NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.29) per share which beat the analyst consensus estimate of $(1.43) by 9.79 percent. This is a 59.94 percent increase over losses of $(3.22) per share from the same
NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.29) per share which beat the analyst consensus estimate of $(1.43) by 9.79 percent. This is a 59.94 percent increase over losses of $(3.22) per share from the same period last year.